%A Schulz,Martin S. %A Gu,Wenyi %A Schnitzbauer,Andreas A. %A Trebicka,Jonel %D 2022 %J Transplant International %C %F %G English %K liver transplantation,decompensated cirrhosis,Liver cirrhosis,ACLF,acute-on-chronic liver failure %Q %R 10.3389/ti.2022.10108 %W %L %M %P %7 %8 2022-March-17 %9 Review %# %! LT is crucial for ACLF %* %< %T Liver Transplantation as a Cornerstone Treatment for Acute-On-Chronic Liver Failure %U https://www.frontierspartnerships.org/articles/10.3389/ti.2022.10108 %V 35 %0 JOURNAL ARTICLE %@ 1432-2277 %X Acute-on-chronic liver failure (ACLF) is a distinct clinical syndrome, characterized by acute decompensation (AD) of liver cirrhosis, severe systemic inflammation, intra- and extrahepatic organ failures, and a high short-term mortality. Liver transplantation (LT) is a potentially life-saving treatment for patients with decompensated liver cirrhosis and, due to the high mortality rates, particularly for ACLF patients. In the last decade, a plethora of studies has produced compelling evidence in favor of LT in ACLF, demonstrating high post-LT survival rates and excessive waitlist mortality. The importance of LT in these patients is underscored by the fact that no specific therapy for ACLF is available yet, rendering expeditious life-saving LT to be the only feasible treatment option for some ACLF patients. This review aims to provide an overview on pathophysiology, clinical trajectory, and clinical management of ACLF and to delineate the current literature regarding perspectives and limitations of LT as a life-saving treatment option for ACLF patients.